Neuroblastoma cells negative for CD44 possess tumor-initiating properties

Author： Siapati Elena  

Publisher： Springer Publishing Company

ISSN： 2211-3428

Source： Cellular Oncology, Vol.34, Iss.3, 2011-06, pp. : 189-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CD44 and EpCAM: Cancer-Initiating Cell Markers

By  

Current Molecular Medicine, Vol. 8, Iss. 8, 2008-12 ,pp. : 784-804

Bentham Science Publishers

Access to resources Recommend Favorite

Motility of colon cancer cells: modulation by CD44 isoform expression

By Wong K.   Rubenthiran U.   Jothy S.  

Experimental and Molecular Pathology, Vol. 75, Iss. 2, 2003-10 ,pp. : 124-130

Elsevier

Access to resources Recommend Favorite

Glioblastoma Tumor Initiating Cells: Therapeutic Strategies Targeting Apoptosis and MicroRNA Pathways

By  

Current Molecular Medicine, Vol. 13, Iss. 3, 2013-03 ,pp. : 352-357

Bentham Science Publishers

Access to resources Recommend Favorite

Tumor necrosis factor- inhibits generation of glycophorin A + cells by CD34 + cells

By Xiao W.   Koizumi K.   Nishio M.   Endo T.   Osawa M.   Fujimoto K.   Sato I.   Sakai T.   Koike T.   Sawada K.-i.  

Experimental Hematology, Vol. 30, Iss. 11, 2002-11 ,pp. : 1238-1247

Elsevier

Access to resources Recommend Favorite

Myeloid-lymphoid initiating cells (ML-IC) are highly enriched in the rhodamine-c-kit + CD33 - CD38 - fraction of umbilical cord CD34 + cells

By Liu H.   Verfaillie C.M.  

Experimental Hematology, Vol. 30, Iss. 6, 2002-06 ,pp. : 582-589

Elsevier

Access to resources Recommend Favorite